Skip To Main Content
Barbara McGowan on Muck Rack

Barbara McGowan

As seen in: Nature, Wiley Online Library, BMJ Open, BMJ Open Diabetes Research & Care, The New England Journal of Medicine, The Lancet, The New Statesman, BBC Science Focus, King's College London, medRxiv and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara

Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Causes and consequences of discontinuation of GLP1RAs or tirzepatide

|
By Antonio Ceriello, Francesco Prattichizzo, Rosalba La Grotta, Cesare Celeste Berra, Barbara McGowan, Alicia Jenkins, Neale Cohen, Giuseppina Russo, Michael Albrecht Nauck
| Nature Verified
Abstract Glucagon-like peptide 1 (GLP1) receptor (GLP1R) agonists and tirzepatide, a dual GLP1R and glucose-dependent insulinotropic polypeptide receptor agonist, have become fundamental in managing type 2 diabetes mellitus (T2DM) and obesity due to their potent glycaemia-lowering and weight-lowering effects as well as their cardiovascular and renal benefits.
Open in Who Shared Issue with article?

Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update

|
By Andreea Ciudin, Jennifer Baker, Luca Busetto, Dror Dicker, Gema Frühbeck, Gijs H. Goossens, Jason Gordon, Matteo Monami, Paolo Sbraccia, Borja Martinez-Tellez, Volkan Yumuk, Barbara McGowan
| Nature Verified
This 2026 update integrates emerging trial evidence — particularly for weight loss and liver disease — to refine EASO’s treatment algorithm for obesity management.
Open in Who Shared Issue with article?

Development of the European Association for the Study of Obesity (EASO) Grade-Based Framework on the Pharmacological Treatment of Obesity: Design and Methodological Aspects.

|
By Barbara McGowan, Andreea Ciudin, Jennifer Baker, Luca Busetto
| medRxiv
The authors have declared no competing interest. This study did not receive any funding I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Open in Who Shared Issue with article?
See all 16 licensed articles (19 Total)